Advances in breast cancer diagnosis are helping doctors to precisely investigate different breast tumor types and provide personalized treatment for patients. One may be advised to take hormone-blocking tablets and, based on further testing, may safely avoid chemotherapy.
Tavishi Dogra is a Deputy Chief Content Producer, Health & Wellness, at Hindustan Times. She joined Hindustan Times to simplify wellness subjects by cutting through jargon. She has over 9 years of experience writing about fitness, nutrition, and mental well-being, translating medical research and expert insights into practical advice readers can trust. Career journey and experience Tavishi began her health journalism journey in 2017, and has since reported for RSTV, Financial Express, Jagran, HT Media Labs and Zee.
Education and professional background Tavishi holds a Master’s degree in Journalism and Mass Communication and began her career reporting on public affairs for broadcast. Editorial Philosophy I write with one single goal: To simplify health in a world full of noise by finding what’s actually doable, safe, and evidence-based for my readers. I test claims against research and user experiences. Why do their treatment plans differ despite having seemingly similar breast cancer? Understanding these differences helps doctors select the most appropriate treatment for each patient. HER2 testing checks for excess HER2 protein expression, which promotes cancer growth. No single marker defines a tumour’s molecular signature. advanced genetic and genomic tests play an important role in prognosis, treatment selection, family counseling, determining drug efficacy, and monitoring recurrence or relapse of cancers While routine pathology and receptor testing provide the foundation for treatment decisions. Depending on test results, Oncologists discuss treatment choices, surgical decisions, future cancer screening, and risk assessment tests with patients and family members. A genetic test result isn’t just information for the patient; it’s information for the entire family. Genomic testing in the early stages of cancer helps examine the activity of multiple cancer-causing genes to estimate the risk of cancer recurrence (cancer relapse) and guide treatment decisions. Beyond diagnosis, other genomic tests look for specific DNA changes that may guide targeted treatment, particularly in advanced cancer. ( Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.)
When all else fails, I speak to the expert who sees 50 patients a day, not the one with the most followers. Because eR and PR stimulate tumor growth, these include estrogen receptor (ER) and progesterone receptor (PR) tests that determine whether cancer cells respond to hormonal therapy,.
“The other may need surgery, radiation therapy, chemotherapy, targeted therapy, or a combination of treatments”, Dr Prashanth Bagali, Head of Scientific Affairs, Oncology and Rare Diseases, MedGenome Labs Ltd, tells Health Shots . Those early years in policy and TV shaped how she writes today: fast, factual, and human-first.
Subject expertise With 9+ years tracking India’s health conversations, Tavishi knows the gap between clinical advice and daily life. She knows fads from fundamentals and curates science-backed, expert-recommended solutions. In fitness, she breaks down bodyweight training, recovery, and posture fixes for desk-bound readers. In nutrition, she translates guidelines into affordable, desi meal tweaks. In mental well-being, she focuses on stigma-free, actionable tools — all backed by research, expert input, and lived context.
From decoding health trends and interviewing doctors to testing fitness routines herself, Tavishi always approaches content with one filter: “Will this help someone make a better decision today?
